Species differences in the hepatic and intestinal metabolism of cyclosporine

被引:35
作者
Whalen, RD [1 ]
Tata, PNV [1 ]
Burckart, GJ [1 ]
Venkataramanan, R [1 ]
机构
[1] Univ Pittsburgh, Sch Pharm, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA
关键词
D O I
10.1080/004982599238777
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
1. Cyclosporin A (cyclosporine, CSA) is an immunosuppressive drug with a narrow therapeutic index. In the present study the metabolism of CSA was investigated in the liver and small intestinal microsomes obtained from rat, hamster, rabbit, dog, baboon and man by measuring the disappearance of CSA and the formation of the principal metabolites of CSA, namely hydroxylated and N-demethylated CSA. 2. CSA was metabolized at a very slow rate (2-8 % metabolism in 30 min) in rat liver microsomes whereas microsomes from dog livers were very efficient (70-100 % metabolism in 30 min) in metabolizing CSA. Hydroxylation and N-demethylation accounted for most of the CSA metabolized in all the species tested. 3. Microsomes from the small intestine produced qualitatively a similar metabolic profile as compared with the microsomes from the liver, but at a slower rate in all the species tested. The relative importance of the different metabolic pathways, however, differed between species. 4. This study points to the importance of recognizing the similarities and the differences in the metabolism of CSA in different species when data from animal studies are extrapolated to man.
引用
收藏
页码:3 / 9
页数:7
相关论文
共 15 条
[1]   URINARY-EXCRETION OF CYCLOSPORINE AND 17 OF ITS METABOLITES IN RENAL-ALLOGRAFT RECIPIENTS [J].
BLECK, JS ;
SCHLITT, HJ ;
CHRISTIANS, U ;
THIESEMANN, C ;
STROHMEYER, S ;
SCHOTTMANN, R ;
KOHLHAW, K ;
WONIGEIT, K ;
SEWING, KF .
PHARMACOLOGY, 1989, 39 (03) :160-164
[2]   THE EFFECTS OF KETOCONAZOLE ON THE INTESTINAL METABOLISM AND BIOAVAILABILITY OF CYCLOSPORINE [J].
GOMEZ, DY ;
WACHER, VJ ;
TOMLANOVICH, SJ ;
HEBERT, MF ;
BENET, LZ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1995, 58 (01) :15-19
[3]  
GORNALL AG, 1949, J BIOL CHEM, V177, P751
[4]   BIOAVAILABILITY OF CYCLOSPORINE WITH CONCOMITANT RIFAMPIN ADMINISTRATION IS MARKEDLY LESS THAN PREDICTED BY HEPATIC ENZYME-INDUCTION [J].
HEBERT, MF ;
ROBERTS, JP ;
PRUEKSARITANONT, T ;
BENET, LZ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (05) :453-457
[5]   CYCLOSPORINE METABOLISM BY P450IIIA IN RAT ENTEROCYTES - ANOTHER DETERMINANT OF ORAL BIOAVAILABILITY [J].
KOLARS, JC ;
STETSON, PL ;
RUSH, BD ;
RUWART, MJ ;
SCHMIEDLINREN, P ;
DUELL, EA ;
VOORHEES, JJ ;
WATKINS, PB .
TRANSPLANTATION, 1992, 53 (03) :596-602
[6]  
OMURA T, 1964, J BIOL CHEM, V239, P237
[7]  
SCHWINGHAMMER TL, 1991, BRIT J CLIN PHARMACO, V32, P2797
[8]   SPECIES-DIFFERENCES IN METABOLISM AND PHARMACOKINETICS - ARE WE CLOSE TO AN UNDERSTANDING [J].
SMITH, DA .
DRUG METABOLISM REVIEWS, 1991, 23 (3-4) :355-373
[9]   ISOLATION OF RAT INTESTINAL MICROSOMES WITH STABLE CYTOCHROME-P-450 AND THEIR METABOLISM OF BENZO (ALPHA)PYRENE [J].
STOHS, SJ ;
GRAFSTROM, RC ;
BURKE, MD ;
MOLDEUS, PW ;
ORRENIUS, SG .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1976, 177 (01) :105-116
[10]  
VENKATARAMANAN R, 1988, TRANSPLANT P, V20, P680